RobertLRednerMD
Hematology • Pittsburgh, PAProfessor, Medicine, University of Pittsburgh School of Medicine
Dr. Redner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5115 Centre Avenue
Upmc Cancer Pavillion
Pittsburgh, PA 15232Phone+1 412-692-4724- Is this information wrong?
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1983 - 1984
Johns Hopkins UniversityResidency, Internal Medicine, 1980 - 1983
Harvard Medical SchoolClass of 1980
Certifications & Licensure
CA State Medical License 1983 - Present
PA State Medical License 1991 - 2024
MD State Medical License 1984 - 1993- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia Start of enrollment: 2008 Sep 01
- A Randomized Clinical Trial of Lenalidomide (CC-5013) and Dexamethasone With and Without Autologous Peripheral Blood Stem Cell Transplant in Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2008 Jan 01
- Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome Start of enrollment: 2011 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients.Normolle, D., Bovbjerg, D., Im, A., Quann, K., Agha, M., Raptis, A., Redner, R., Hou, J., Farah, R., Dorritie, K., Sehgal, A., Aggarwal, N., Herman, J., Lontos, K., Bo...> ;American Journal of Hematology. 2024 Mar 1
- 1 citationsEntospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.Vu H Duong, Amy S Ruppert, Alice S Mims, Uma Borate, Eytan M Stein, Maria R Baer, Wendy Stock, Tibor Kovacsovics, William Blum, Martha L Arellano, Gary J Schiller, Reb...> ;Cancer. 2023 Aug 1
- Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy.Konstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L Redner, Annie Im, Kathleen A Dorritie, Alison Sehgal, J...> ;Leukemia & Lymphoma. 2023 Mar 1
- Join now to see all
Grant Support
- Characterization Of A Novel Translocation Product In APLNational Cancer Institute2006–2009
- Calcitriol &Dexamethasone For Myelodysplastic SyndromesFood And Drug Administration2004
- Vitamin D And Dexamethasone In Myelodysplastic SyndromesNational Cancer Institute2002–2003
- Novel Translocation Product In APLNational Cancer Institute1995–1999
Hospital Affiliations
UPMC Presbyterian ShadysidePittsburgh, Pennsylvania
UPMC Magee-Womens HospitalPittsburgh, Pennsylvania- Shadyside CampusPittsburgh, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
